Regenerating pancreatic beta-cells: plasticity of adult pancreatic cells and the feasibility of in-vivo neogenesis
- PMID: 19907327
- PMCID: PMC2834213
- DOI: 10.1097/MOT.0b013e3283344932
Regenerating pancreatic beta-cells: plasticity of adult pancreatic cells and the feasibility of in-vivo neogenesis
Abstract
Purpose of review: Diabetes results from inadequate functional mass of pancreatic beta-cells and therefore replenishing with new glucose-responsive beta-cells is an important therapeutic option. In addition to replication of pre-existing beta-cells, new beta-cells can be produced from differentiated adult cells using in-vitro or in-vivo approaches. This review will summarize recent advances in in-vivo generation of beta-cells from cells that are not beta-cells (neogenesis) and discuss ways to overcome the limitations of this process.
Recent findings: Multiple groups have shown that adult pancreatic ducts, acinar and even endocrine cells exhibit cellular plasticity and can differentiate into beta-cells in vivo. Several different approaches, including misexpression of transcription factors and tissue injury, have induced neogenesis of insulin-expressing cells in vivo and ameliorated diabetes.
Summary: Recent breakthroughs demonstrating cellular plasticity of adult pancreatic cells to form new beta-cells are a positive first step towards developing in-vivo regeneration-based therapy for diabetes. Currently, neogenesis processes are inefficient and do not generate sufficient amounts of beta-cells required to normalize hyperglycemia. However, an improved understanding of mechanisms regulating neogenesis of beta-cells from adult pancreatic cells and of their maturation into functional glucose-responsive beta-cells can make therapies based on in-vivo regeneration a reality.
Figures
References
-
- Bonner-Weir S, Inada A, Yatoh S, et al. Transdifferentiation of pancreatic ductal cells to endocrine beta-cells. Biochem Soc Trans. 2008 Jun;36(Pt 3):353–6. - PubMed
-
- Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008 Oct 2;455(7213):627–32. - PMC - PubMed
-
Paper provides evidence for reprogramming of adult pancreatic cells by demonstrating that in vivo misexpression of Ngn3, Pdx1 and MafA in adult acinar cells converts them to insulin-producing cells.
-
- Collombat P, Xu X, Ravassard P, et al. The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into [alpha] and Subsequently [beta] Cells. Cell. 2009;138(3):449–62. - PMC - PubMed
-
Authors provide genetic evidence that Pax4 induced in adult glucagon-expressing cells transdifferentiate them to β-cells. Furthermore, hypoglycemic condition triggers neogenesis of α-cells that upon expression of Pax4 transdifferentiate into β-cells.
-
- Xu X, D'Hoker J, Stange G, et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell. 2008 Jan 25;132(2):197–207. - PubMed
-
Manuscript provides evidence for in vivo neognesis of β-cells. This study demonstrates induction of Ngn3-expressing cells in adults upon ductal ligation and that the neogenesis of b-cells depends on the expression of Ngn3.
-
- Inada A, Nienaber C, Katsuta H, et al. Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19915–9. - PMC - PubMed
-
Paper shows genetic lineage tracing evidence that newly formed endocrine cells are derived from CAII expressing duct cells both in neonatal stage and in adult pancreas following duct ligation.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
